The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis.
Daniel Costin Danila
No relevant relationships to disclose
Aseem Anand
No relevant relationships to disclose
Jianchao Yao
No relevant relationships to disclose
Magdalena Gierszewska
No relevant relationships to disclose
Melissa Kramer
No relevant relationships to disclose
Stephanie Muller
No relevant relationships to disclose
Martin Fleisher
No relevant relationships to disclose
William R. McCombie
No relevant relationships to disclose
Howard I. Scher
Consultant or Advisory Role - Medivation (U)
Research Funding - Medivation